Markets

Proteon Therapeutics (PRTO) in Focus: Stock Gains 6.4%

Proteon Therapeutics IncPRTO was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 23.2% in the past one-month time frame.

The company has seen no estimate revisions over the past 30 days, while the Zacks Consensus Estimate remained unchanged over the same time frame. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Proteon Therapeutics currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

PROTEON THERAPT Price

PROTEON THERAPT Price | PROTEON THERAPT Quote

A better-ranked stock in the Med-Biomed/Gene industry is ANI Pharmaceuticals, Inc. ANIP , which sports a Zacks Rank #1 (Strong Buy).

Is PRTO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PROTEON THERAPT (PRTO): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANIP TARA

Other Topics

Investing Stocks

Latest Markets Videos